Files
Document type
ArticleVersion
Published versionPublication date
Publication license
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/176656
Phage-Encoded Endolysins
Journal Title
Director/Tutor
Journal ISSN
Volume Title
Related resource
Abstract
Due to the global emergence of antibiotic resistance, there has been an increase in research surrounding endolysins as an alternative therapeutic. Endolysins are phage-encoded enzymes, utilized by mature phage virions to hydrolyze the cell wall from within. There is significant evidence that proves the ability of endolysins to degrade the peptidoglycan externally without the assistance of phage. Thus, their incorporation in therapeutic strategies has opened new options for therapeutic application against bacterial infections in the human and veterinary sectors, as well as within the agricultural and biotechnology sectors. While endolysins show promising results within the laboratory, it is important to document their resistance, safety, and immunogenicity for in-vivo application. This review aims to provide new insights into the synergy between endolysins and antibiotics, as well as the formulation of endolysins. Thus, it provides crucial information for clinical trials involving endolysins.
Subject (English)
Citation
Citation
ABDELRAHMAN, Fatma, et al. Phage-Encoded Endolysins. Antibiotics. 2021. Vol. 10, num. 2, pags. 124. ISSN 2079-6382. [consulted: 10 of August of 2026]. Available at: https://hdl.handle.net/2445/176656